Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-1384PMID 15574789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The total test approach to standardization of immunohistochemistry.

  2009cited by this paper
• The total test approach to standardization of immunohistochemistry.

  2009cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Application of new in situ hybridization probes for Ku70 and Ku80 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemical analysis.

  2004cited by this paper
• Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.

  2004cited by this paper
• MDM2 and prognosis.

  2004cited by this paper
• Dynamics of the p53-Mdm2 feedback loop in individual cells

  2004cited by this paper
• Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

  2004cited by this paper
• The p53-Mdm2 module and the ubiquitin system.

  2003cited by this paper
• Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

  2003cited by this paper
• Cell cycle regulatory functions of the human oncoprotein MDM2.

  2003cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.

  2003cited by this paper
• MDM2, an introduction.

  2003cited by this paper
• p53-independent functions of MDM2.

  2003cited by this paper
• Cancer Statistics, 2002

  2002cited by this paper
• Oncogenic ras and p53 Cooperate To Induce Cellular Senescence

  2002cited by this paper
• Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion

  2002cited by this paper
• HDM2 protein overexpression and prognosis in primary malignant melanoma.

  2002influential reference
• Automated subcellular localization and quantification of protein expression in tissue microarrays

  2002influential reference
• Diagnostic Immunohistochemistry

  2002cited by this paper
• HER-2/neu in Breast Cancer: Interobserver Variability and Performance of Immunohistochemistry with 4 Antibodies Compared with Fluorescent In Situ Hybridization

  2001cited by this paper
• Nuclear and mitochondrial apoptotic pathways of p53

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Tissue microarray: a new technology for amplification of tissue resources.

  2001cited by this paper
• Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

  2001cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Validation of Tissue Microarray Technology in Breast Carcinoma

  2000cited by this paper
• Analysis of G1/S checkpoint regulators in metastatic melanoma

  2000cited by this paper
• Molecular classification of cutaneous malignant melanoma by gene expression profiling

  2000cited by this paper
• Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation.

  1999cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Prognostic value of biomarkers in malignant melanoma

  1998cited by this paper
• DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.

  1997cited by this paper
• Mdm2: keeping p53 under control

  1997cited by this paper
• The incidence of malignant melanoma in the United States: issues as we approach the 21st century.

  1996cited by this paper
• The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry.

  1996cited by this paper
• p53 and MDM2 expression in oral squamous cell carcinoma.

  1996cited by this paper
• C-erbB-2 immunostaining: problems with interpretation.

  1994cited by this paper
• Immunohistochemistry in the diagnosis of melanocytic neoplasms.

  1994cited by this paper
• Cancer statistics

  1989cited by this paper
• The developmental biology of primary human malignant melanomas.

  1975cited by this paper
• Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma

  1970influential reference

• Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy

  2021cites this paper
• Epidermal Cells: Methods and Protocols

  2020cites this paper
• PD-L1 Detection-Pearls and Pitfalls Associated With Current Methodologies Focusing on Entities Relevant to Dermatopathology.

  2019cites this paper
• Selection of Intensity Distribution Characteristics in the Color Channels of Fluorescent Images of Cancer Cells

  2019cites this paper
• Digital Quantification of Epidermal Protein Expression in Paraffin-Embedded Tissue Using Immunohistochemistry.

  2019cites this paper
• AN OPTIMALDILUTION OF A REAGENT

  2017cites this paper
• COMPARTMENT SEGREGATION BY PIXEL 12 : A 3

  2017cites this paper
• Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism.

  2016cites this paper
• Comparative analysis of colorimetric staining in skin using open‐source software

  2015cites this paper
• Simulation Model for Three-Channel Luminescent Images of Cancer Cell Populations

  2015cites this paper
• Expression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA).

  2015cites this paper
• Tissue prognostic biomarkers in primary cutaneous melanoma

  2014cites this paper
• Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis

  2014cites this paper
• Multispectral Imaging

  2014cites this paper
• Development of DNA Damage Response Signaling Biomarkers using Automated, Quantitative Image Analysis

  2014cites this paper
• Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.

  2014cites this paper
• Identifying a hyperkeratosis signature in autosomal recessive congenital ichthyosis: Mdm2 inhibition prevents hyperkeratosis in a rat ARCI model.

  2014cites this paper
• Prognostic value of Musashi-1 in gliomas

  2013cites this paper
• For Peer Review MicroRNA & cutaneous melanoma: from discovery to prognosis and therapy

  2012cites this paper
• Human Cancer Biology Punctate LC 3 B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation , Metastasis , and Poor Outcome

  2012cites this paper
• Serum microRNAs as biomarkers for recurrence in melanoma

  2012cites this paper
• MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.

  2012cites this paper
• Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.

  2012cites this paper
• Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.

  2012cites this paper
• Tissue microarrays and quantitative tissue-based image analysis as a tool for oncology biomarker and diagnostic development.

  2012cites this paper
• Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (B) Prognostication

  2012cites this paper
• Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome

  2011cites this paper
• Cell penetrating peptides for tumor targeting.

  2011cites this paper
• Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma

  2011cites this paper
• p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation

  2010cites this paper
• Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

  2010cites this paper
• Melanoma Tissue Microarray (TMA) Cohort and Data Repository

  2010cites this paper
• Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis

  2009cites this paper
• Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

  2009cites this paper
• Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

  2009cites this paper
• Association of MDM 2 SNP 309 , Age of Onset , and Gender in CutaneousMelanoma

  2009cites this paper
• A systems biology approach to defining metastatic biomarkers and signaling pathways

  2009cites this paper
• Protein Transduction Domain-Mediated Delivery of Anticancer Proteins

  2009cites this paper
• Identification and functional validation of therapeutic targets for malignant melanoma.

  2009influential citation
• Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort

  2009cites this paper
• Immunohistochemistry and quantitative analysis of protein expression.

  2009cites this paper
• Crosstalk Between MDM2 and Akt Signaling Pathway in Oncogenesis.

  2008cites this paper
• The role of p53 in pigmentation, tanning and melanoma

  2008cites this paper
• Bioimaging for analysis of protein expression in cells and tissues using affinity reagents

  2008cites this paper
• Procurement of Human Melanoma Specimens for Translational Research: Practical and Legal Considerations

  2008cites this paper
• Antibody-based profiling of expression patterns using cell and tissue microarrays.

  2008cites this paper
• Development and validation of software solutions to eliminate bottlenecks in the application of high-throughput quantitative immunohistochemistry

  2008cites this paper
• The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization

  2007cites this paper
• Tissue Microarrays in Prostate Cancer Research

  2007cites this paper
• A high‐throughput strategy for protein profiling in cell microarrays using automated image analysis

  2007cites this paper
• Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma

  2007cites this paper
• Expression of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptors 1 and 2 in Melanoma

  2006cites this paper
• Antitumor protein therapy; Application of the protein transduction domain to the development of a protein drug for cancer treatment

  2006cites this paper
• Downregulation of MDM2 expression by RNAi inhibits LoVo human colorectal adenocarcinoma cells growth and the treatment of LoVo cells with mdm2siRNA3 enhances the sensitivity to cisplatin.

  2006cites this paper
• Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.

  2006cites this paper
• Microarrays as Validation Strategies in Clinical Samples: Tissue and Protein Microarrays

  2006cites this paper
• Tissue microarrays – automated analysis and future directions

  2005cites this paper
• Evaluating the Expression and Prognostic Value of TRAIL-R1 and TRAIL-R2 in Breast Cancer

  2005cites this paper
• Rodent models of brain metastasis in melanoma

  2005cites this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cites this paper
• Coexpression of β1,6-N-Acetylglucosaminyltransferase V Glycoprotein Substrates Defines Aggressive Breast Cancers with Poor Outcome

  2005cites this paper
• A history of microarrays in biomedicine

  2005cites this paper
• Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.

  2005cites this paper
• Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.

  2005cites this paper
• Automated Quantitative Analysis of E-Cadherin Expression in Lymph Node Metastases Is Predictive of Survival in Invasive Ductal Breast Cancer

  2005cites this paper
• Quantitative in situ cancer proteomics: molecular pathology comes of age with automated tissue microarray analysis.

  2005cites this paper
• Technology Insight: identification of biomarkers with tissue microarray technology

  2004cites this paper